Neurotech Advisory Practice

Commercial neurotech markets are changing fast.

How are you keeping up?

We support the industry’s leading founders, investors, and business leaders operating in BCI, neuromodulation, and consumer health.

Our service is designed for executives seeking dedicated fractional support on market intelligence and commercial strategy

  • understanding activity in market segments

  • custom memos on specific topics or companies

  • monthly call and leave-behind memos

This advisory service is not deliverables driven consulting. It’s behind the scenes monthly support, semi-structured and ad-hoc.

  • 6 month and 12 month packages available.

  • Limited availability. First-come, first serve.

  • Enquire today!

Unparalleled Depth and Expertise in Neurotech Market Research

We are formally offering neurotech advisory services following three years of tracking companies, markets, and trends at the intersection of neuroscience R&D and artificial intelligence in our industry leading newsletter, Neurotech Futures.

This work is marks a decade of Patchwise Labs supporting startups across health IT, digital health, DTx, social determinants of health, and life sciences, and now neurotech.

We’ve conducted deep dives on 200+ global neurotech startups, spanning history, leadership, clearances, patents, trials, partnerships, federal contracts, M&A, strategies, news, and more. We have advised founders and investors behind some of the top neurotech startups on developing go to market strategies, leading competitive intel, and narrative positioning for fundraising and public relations.

Our focus is uniquely holistic, from wearables to implantables, life sciences to digital health to back end AI. We won’t claim we know it all - but we can say with exactitude that we know where to look, who to talk to, what questions to ask, and how to connect the dots productively for you.

We’ve built a unique and unparalleled executive network underpinning a vibrant, global ecosystem of startups, technologists, advocates, consultants, investors, regulatory experts, and other business leaders with shared values and interests in building a safe, autonomous, and just future for neurotechnology. This informs all of our consulting, advising, and creative services.

Since 2023, Patchwise Labs has support federal neurotechnology commercialization efforts through ARPA-H’s Spoke-and-Hub model, serving both the Investor Catalyst Hub and Customer Experience Hub with applied market insights and leveraged network expertise. We are also a designated SME/Consultant to the NIH’s Blueprint MedTech program, which operates Center for Innovative Neurotech Advancement (CINTA) and Neurotech Harbor.

 
 

Other Ways To Work With Us

Collaboration opportunities are available across the Neurotech Futures Ecosystem.